Patent details

Basic Information

Publication number:

EP2335725

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP100089804

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

High concentration antibody and protein formulations

French Title of Invention:

Formulations d'anticorps et de protéines à forte concentration

German Title of Invention:

Hochkonzentrierte Antikörper- und Proteinformulierungen

SPC Number:

Dates

Filing date:

29/03/2004

Grant date:

12/10/2016

EP Publication Date:

12/10/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/06/2011

EP B1 Publication Date:

12/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/03/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/03/2004

 

 

Name:

Genentech Inc.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

21/12/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Shire Steven

Address:

United States (US)

2

Name:

Liu Jun

Address:

United States (US)

Priority

Priority Number:

460659 P

Priority Date:

04/04/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

15/02/2023

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages